Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
3rd Dec 20155:42 pmRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
26th Nov 20153:56 pmRNSDirector/PDMR Shareholding
10th Nov 20152:34 pmRNSHolding(s) in Company
6th Nov 201512:06 pmRNSHolding(s) in Company
5th Nov 20154:48 pmRNSResult of AGM
5th Nov 20157:00 amRNSAGM and Interim Management Statement
2nd Nov 201510:50 amRNSTotal Voting Rights
20th Oct 20156:16 pmRNSDirector/PDMR Shareholding
19th Oct 20154:03 pmRNSShare Awards
8th Oct 20154:47 pmRNSHolding(s) in Company
1st Oct 201510:24 amRNSTotal Voting Rights
25th Sep 20153:28 pmRNSHolding(s) in Company
17th Sep 20153:06 pmRNSShares Awards
15th Sep 20157:00 amRNSFinal Results
8th Sep 20157:00 amRNSBoard Changes
1st Sep 20152:19 pmRNSHolding(s) in Company
1st Sep 201512:20 pmRNSTotal Voting Rights
11th Aug 20152:00 pmRNSNotice of Results
6th Aug 20153:10 pmRNSHolding(s) in Company
3rd Aug 201511:33 amRNSTotal Voting Rights
31st Jul 20157:00 amRNSHolding(s) in Company
15th Jul 20154:42 pmRNSHolding(s) in Company
15th Jul 20157:00 amRNSHolding(s) in Company
8th Jul 201511:36 amRNSHolding(s) in Company
8th Jul 201511:30 amRNSHolding(s) in Company
7th Jul 20158:00 amRNSCapital Markets Day
7th Jul 20157:00 amRNSAcquisition of Financial Research Associates LLC
2nd Jul 201510:44 amRNSTotal Voting Rights
2nd Jul 20157:00 amRNSExtension of Debt Facility
2nd Jun 20159:19 amRNSPDMR Share Purchase
1st Jun 20153:08 pmRNSTotal Voting Rights
6th May 20157:01 amRNSInterim Management Statement
1st May 201510:14 amRNSTotal Voting Rights
1st Apr 201510:25 amRNSTotal Voting Rights
25th Mar 20154:44 pmRNSHolding(s) in Company
2nd Mar 201510:40 amRNSVoting Rights
27th Feb 20159:16 amRNSChange of Name
25th Feb 201511:58 amRNSShareholding Announcement
25th Feb 20157:01 amRNSHalf Year Results
19th Feb 20159:33 amRNSHolding(s) in Company
3rd Feb 20154:40 pmRNSTotal Voting Rights
26th Jan 201510:14 amRNSHolding(s) in Company
23rd Jan 20153:12 pmRNSHolding(s) in Company
23rd Jan 20151:59 pmRNSHolding(s) in Company
22nd Jan 201510:03 amRNSHolding(s) in Company
14th Jan 20153:54 pmRNSNotice of Results
5th Jan 20157:00 amRNSVoting Rights and Capital
10th Dec 20147:01 amRNSBoard Change
10th Dec 20147:00 amRNSInterim Update on Business Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.